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In mammalian cells, the splicing machinery deposits the exon junction complex (EJC) on mRNA 
splice junctions. Two studies in this issue now link the EJC to different aspects of translational 
control. Ma et al. (2008) show that the EJC activates translation downstream of the mTOR signaling 
pathway, whereas Isken et al. (2008) establish that translation is repressed by partners of the EJC 
that are implicated in nonsense mediated decay (NMD).A eukaryotic messenger RNA (mRNA) contains not only a com-
plete open reading frame to serve as a template for protein 
synthesis, but also information that regulates its export from 
the nucleus, subcellular localization, translation, and stabil-
ity. Much of this information is carried by the proteins bound 
to the mRNA that comprise mRNA-protein (mRNP) particles 
(Moore, 2005). However, the acquisition of these trans-acting 
factors is not simply attributable to the primary sequence of 
the transcript. The composition of pre-mRNP particles is highly 
dynamic and evolves at each step of its processing, including 
pre-mRNA transcription, polyadenylation, splicing, and export. 
One of the important challenges for understanding the regula-
tion of gene expression in eukaryotes is determining how the 
history of an mRNP in the nucleus affects its function in the 
cytoplasm and the amount of the corresponding protein that 
is produced.
One hint that the nuclear history of an mRNA affects its 
fate in the cytoplasm comes from the analysis of nonsense 
mediated decay (NMD) in mammalian cells (reviewed in 
Chang et al., 2007; Conti and Izaurralde, 2005). NMD is a 
process by which mRNAs carrying premature stop codons 
(which may encode deleterious proteins) are selectively rec-
ognized and destroyed. In mammalian cells, stop codons 
must be located at least 50 nucleotides upstream of the 3′ 
splice junction to be recognized as premature. Strikingly, 
this finding indicated that mRNA decay in the cytoplasm was 
somehow controlled by an event occurring in the nucleus. A 
molecular explanation for these observations was provided 
by the identification of the exon junction complex (EJC) (Le 
Hir et al., 2000).
In mammalian cells, the EJC is assembled concomitantly 
with splicing and binds tightly to a newly formed mRNA at 
a region 24 nucleotides upstream of splice junctions. The 
EJC is transported with the mature mRNA to the cytoplasm 
and remains associated with the mRNP until the mRNA is 
translated. Although the core of the EJC remains unchanged 
during mRNP maturation, peripheral proteins associate 
and dissociate throughout the mRNP’s journey in the cell. 
The EJC is involved in various cellular processes, includ-
ing nucleocytoplasmic mRNA export, subcellular localiza-
tion, quality control, and translation (Giorgi and Moore, 2007; Tange et al., 2004). Two reports in this issue, by Ma 
et al. (2008) and Isken et al. (2008), reveal new insights into 
mechanisms by which the EJC and its associated proteins 
activate or repress translation.
mTOR Signaling and the EJC
The TOR signaling pathway plays a major role in the regulation 
of cell growth. TOR activity is under the control of a variety 
of external cellular cues ranging from amino acid concentra-
tions to hormones through an intricate cascade of intracellular 
signaling pathways (Bhaskar and Hay, 2007). TOR signals to 
several cellular machineries, including the translation initiation 
apparatus via the S6 kinase (S6K) (Mamane et al., 2006).
In eukaryotic cells, recognition of the mRNA cap, which 
involves the cap-binding complex (CBC) or the translation ini-
tiation factor eIF4E, is a key step in translation as it ensures that 
only intact mRNAs are translated. The CBC interacts with the 
cap of newly made mRNAs in the nucleus and promotes their 
translation in the cytoplasm in the so-called pioneer round of 
translation (Ishigaki et al., 2001). Studies in mammalian cells 
provided evidence that recognition of premature translation 
termination codons (PTC) and NMD occur during the first 
translation event. Building on these observations, Blenis and 
colleagues (Ma et al., 2008) tested whether the mammalian 
TOR (mTOR) pathway would affect the phosphorylation of 
proteins specifically involved in the pioneer round of transla-
tion. An examination of the proteins that coprecipitate with the 
CBC for the presence of possible phosphorylated S6K targets 
indicated that several unidentified factors present during the 
pioneer round of translation are also substrates of the mTOR 
pathway. Moreover, mTOR and one of the two mammalian S6 
kinases (S6K1) were specifically found to associate with these 
factors. These data reveal that the mTOR pathway and trans-
lation of freshly exported mRNAs may be interconnected, 
prompting the search for factors that physically link these two 
processes. A candidate approach indicated that SKAR (S6K1 
Aly/REF-like target), a previously known S6K1 substrate (Rich-
ardson et al., 2004), mediates the recruitment of S6K1 to tar-
get mRNPs. SKAR has an RNA-binding domain and the abil-
ity to shuttle between the nucleus and the cytoplasm—two 
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new mRNPs. SKAR is shown to specifically associate with the 
EJC assembled in vitro. Moreover, this association is required 
for the phosphorylation of downstream targets of S6K1. Most 
importantly, knockdown of SKAR, S6K1, and the EJC using 
short interfering RNAs (siRNAs) demonstrated that they all par-
ticipate in the stimulation of the translation of spliced mRNAs. 
Overall, these data led Blenis and coworkers to propose that 
the mTOR pathway contributes to translation through the 
SKAR-mediated recruitment of S6K1 to newly spliced mRNAs 
(Figure 1).
Although previous work has shown that the EJC affects 
translational efficiency (Nott et al., 2004; Wiegand et al., 2003; 
Diem et al., 2007), the study of Ma et al. (2008) provides a new 
mechanistic description for how this could occur. The authors 
also provide evidence for the existence of several factors phos-
phorylated by S6K1 in initiation complexes bound to the CBC 
factor. It will thus be of interest to determine whether S6K1 
recruitment is sufficient to account for the enhanced transla-
tion efficiency mediated by the EJC or whether other factors 
are participating in this process.
An interesting feature of the EJC is that it distinguishes newly 
formed mRNAs from older templates that have already been 
translated. Hence, an important aspect of the observations 
reported by Blenis and collaborators is that the mTOR/S6K1 
pathway specifically targets newly made mRNAs. Through 
this mechanism, cells further stimulate the production of pro-
teins from genes that have been recently turned on. Overall 
such stimulation shortens the lag time between transcriptional 
induction and downstream biological effects. This is particu-
larly important in eukaryotes, where production of translatable 
mRNAs is often a lengthy process. Indeed, pre-mRNA synthe-
sis often takes dozens of minutes, but 
may in extreme cases last for several 
hours, and is usually followed by com-
plex mRNA processing steps. This time-
consuming process of building an mRNA 
could prevent cells from responding rap-
idly to external stimuli. The targeted stimulation of translation 
of newly made mRNAs through the EJC, SKAR, and mTOR/
S6K1 pathway partly counterbalances the slow rate of mRNA 
production. Given that the first round of translation removes 
EJCs, this effect may be short lived and restricted to a small 
number of translation initiation events, unless substrates of 
S6K1 that favor translation initiation were to remain associated 
with the mRNP following EJC dissociation.
The discovery that SKAR associates with the EJC is sur-
prising. Indeed, previous studies involving the purification of 
mRNPs spliced in vitro failed to identify SKAR (Merz et al., 
2007). A possible explanation for this is that SKAR might join 
some, but not all, EJCs. Given the presence of an RNA-binding 
domain in SKAR, an intriguing possibility is that SKAR may 
preferentially associate with a specific subset of mRNAs (such 
as those that are the primary targets of regulation by S6K).
The Ma et al. (2008) study provides unanticipated insights 
into the mechanism by which the EJC promotes translational 
enhancement. Thus, it may seem ironic that this step forward 
occurs at the same time as another report showing that EJC 
partners have a role in translational repression during the NMD 
process. Yet, these findings are not contradictory but instead 
underscore the central and unexpected role of the EJC in 
translational control.
Upf1 Activation Represses Translation during NMD
NMD recognizes and triggers the degradation of mRNAs bear-
ing a premature translation termination codon (PTC) (Chang 
et al., 2007; Conti and Izaurralde, 2005). NMD is important for 
ridding cells of PTC-containing mRNAs that arise from DNA 
mutation, unproductive DNA rearrangements, or incorrect 
Figure 1. The EJC Can Activate or Inhibit 
Translation
(A) Splicing of a normal pre-mRNA in the nucleus 
generates a functional mRNA containing two exon 
junction complexes (EJCs). SKAR joins one of 
these two EJCs before export of the mRNA to the 
cytoplasm. It is currently unclear whether SKAR 
joins all or only a subset of all EJCs (as depicted 
here). In the cytoplasm, S6K1 joins SKAR and 
stimulates translation upon activation by mTOR, 
at least during the pioneer round of translation.
(B) Transcription of a pre-mRNA containing a pre-
mature termination codon (PTC) leads to the gen-
eration of a nonfunctional mRNA bound by two 
EJCs. Following its transport to the cytoplasm, the 
first translational event leads to the ribosome termi-
nating at the PTC. The SURF complex (containing 
unphosphorylated Upf1), which is assembled on 
this ribosome, then interacts with Upf2 and Upf3 
that have been recruited on a downstream EJC. 
This induces Upf1 phosphorylation, which inhibits 
further rounds of translation initiation through in-
teraction with eIF3 before or concomitant with the 
induction of mRNA decay by the NMD pathway.214 Cell 133, April 18, 2008 ©2008 Elsevier Inc.
mRNA processing. In addition, NMD regulates the expression 
of a significant fraction of normal genes in several eukaryotic 
species. In eukaryotes, the conserved protein core of the NMD 
machinery is composed of the Upf1, Upf2, and Upf3 proteins. 
The central effector is Upf1, an RNA helicase that connects 
translation termination and assembly of the surveillance com-
plex. In most multicellular organisms, cycles of phosphoryla-
tion and dephosphorylation of Upf1 are crucial for NMD. These 
cycles are mediated by SMG1, SMG5, SMG6, and SMG7. PTC-
containing mRNAs marked by the Upf complex are eventually 
degraded in P bodies by the same factors that are involved in 
general mRNA degradation.
Distinguishing PTCs from normal termination codons is an 
essential step of NMD that is only partially understood. The 
prevailing model is that in addition to the recognition of the 
stop codon by the translational machinery, another signal 
downstream of the stop codon is required to define it as pre-
mature. In the budding yeast Saccharomyces cerevisiae, the 
fruit fly Drosophila melanogaster, and the worm Caenorhabdi-
tis elegans, this signal might originate from the abnormally long 
3′UTR generated by the PTC, although the mechanism remains 
to be clarified (Amrani et al., 2004). For most mRNAs in mam-
mals, PTCs have been shown to elicit NMD when positioned 
more than 50 nucleotides upstream of an exon-exon bound-
ary. With a few exceptions, most normal termination codons 
are located downstream of the last intron and most PTC-con-
taining genes that lack introns are immune to NMD. By first 
recruiting Upf3 and then Upf2, the EJC communicates intron 
positions to the NMD machinery.
Our current understanding indicates that triggering of NMD 
may follow a stepwise pathway. (1) During the first round of 
translation, the ribosome terminating on a PTC recruits Upf1 
via its interaction with the release factors eRF1 and eRF3, 
and SMG1 to form the SURF (SMG1-Upf1-eRF1-eRF3) com-
plex (Kashima et al., 2006). (2) This transient SURF complex 
bridges the ribosome with the downstream EJC associated 
with Upf3 and Upf2. (3) The interaction of Upf1 and SMG1 with 
Upf2 bound to the EJC triggers the phosphorylation of Upf1 
by SMG1. (4) The resulting complex, which contains the EJC, 
Upf3, Upf2, and phosphorylated Upf1, represents the key sig-
nal to induce degradation of the mRNA.
In their new study, Isken and colleagues (2008) provide 
molecular insights into a new function of phosphorylated Upf1 
during the last steps of NMD. In addition to triggering degra-
dation of PTC-containing mRNAs, the authors show that Upf1 
decreases translation initiation of its partner mRNA. Indeed, 
downregulation of Upf1 by a small interfering RNA leads to a 
marked increase in the translation efficiency of mRNA report-
ers encoding luciferase. A similar effect is observed when 
translation initiation of a luciferase reporter is driven by the 
internal ribosomal entry site (IRES) of the Hepatitis C virus. 
In contrast to classical 5′ cap-dependent translation initia-
tion, this IRES directly binds to the ribosomal 40S subunit with 
no need for the initiation factors recruited by the cap struc-
ture. This is converted in active 80S ribosomes in a reaction 
requiring the initiation factors eIF2-initiator tRNA and eIF3. The 
authors made the interesting observation that downregulation 
of Upf1 has almost no effect on luciferase translation when it is dependent on the IRES of the cricket paralysis virus (CrPV), 
which undergoes IRES-mediated translation by a mechanism 
independent of translation initiation factors. This result strongly 
argues that Upf1 has a previously unsuspected function as an 
inhibitor of translation initiation. This function of Upf1 seems 
essential for the process of NMD because a well-known NMD 
target (β-globin PTC-39 mRNA) is not subjected to NMD when 
its translation is initiated by the CrPV IRES. Although unlikely, 
an alternative interpretation of this result is that the peculiar 
mode of translation initiation driven by the CrVP IRES prevents 
efficient joining of Upf1 to the translation termination complex.
Phosphorylation of Upf1 constitutes an important step during 
the process of NMD that precedes mRNA degradation. Isken 
and colleagues examined the role of Upf1 phophorylation and 
showed that it inhibits translation initiation. One could imagine 
that the inhibition of translation initiation by phosphorylated 
Upf1 is indirect and a consequence of activation of mRNA 
decay by NMD, which removes mRNA extremities including the 
5′ cap structure and the 3′ poly(A) tail. Indeed, these structures 
are associated with factors important for translation initiation 
including the CBC during the pioneer round of translation or 
the binding of the eIF4F complex to the cap structure, and the 
association of poly(A)-binding protein with the poly(A) tail. How-
ever, their results suggest that Upf1 mostly likely acts directly 
on the initiation phase of translation. First, they show that the 
components of the eIF3 complex are coimmunoprecipitated by 
Upf1 and that this interaction is enhanced when Upf1 is hyper-
phosphorylated. In addition, far-western assays indicate that 
Upf1 interacts with the large subunit of eIF3, eIF3a. Second, 
they employed an in vitro strategy using rabbit reticulocyte 
lysates that recapitulates translation but not mRNA degrada-
tion in vitro. By monitoring the assembly of ribosomal subunits 
on a synthetic mRNA substrate by sucrose-gradient sedimen-
tation, the authors observed that hyperphosphorylated Upf1 
does not affect the recruitment of the 40S/initiator tRNA com-
plex onto the mRNA. However, hyperphosphorylated Upf1 (but 
not wild-type Upf1) precludes the conversion of the 40S/initia-
tor tRNA complex into 80S ribosomes that are competent for 
translation.
In light of their observations, the authors integrate the 
newly proposed function of Upf1 into the current model of 
NMD (Figure 1). During the first round of translation in the 
case of premature translation termination, Upf1 is recruited 
to a ribosome via the assembly of the SURF complex. Then, 
Upf1 and SMG1 associate with the EJC located down-
stream, triggering phosphorylation of Upf1 by SMG1. At 
this stage, phosphorylated Upf1 not only allows the recruit-
ment of mRNA decay factors (by a mechanism that remains 
unclear), but also makes contact with eIF3, preventing the 
initiation of additional rounds of translation. Interestingly, 
recent results indicate that eIF3 is involved in ribosome 
recycling after translation termination (Pisarev et al., 2007), 
suggesting that Upf1 and eIF3 may be properly positioned 
during termination to interact and block further rounds of 
translation. This mechanism would prevent the synthesis of 
truncated proteins. Furthermore, this process may release 
the mRNP particle from the translation machinery, allowing 
access for the decay machinery and/or its transport to a P Cell 133, April 18, 2008 ©2008 Elsevier Inc. 215
body for degradation. This dual function of Upf1 is consis-
tent with the notion that the ultimate purpose of NMD is to 
prevent aberrant protein synthesis more than it is a means to 
shorten the half-life of mRNA substrates.
However, a puzzling result reported by Isken et al. (2008) 
suggests that the situation may be more complex. The 
authors observed that the downregulation of Upf2 or a par-
ticular form of Upf3, Upf3b (also known as Upf3X), by siRNA 
treatment prevented NMD but did not affect translation. This 
observation suggests that different levels of phosphorylated 
Upf1 may be necessary to sustain translation inhibition and 
mRNA decay. One could envisage that translation inhibition 
by phosphorylated Upf1 represents a pathway that is inde-
pendent of the NMD process. Further studies will be neces-
sary to determine the connection between these two events. 
Along this line, it will be important to test whether Upf1 also 
affects translation initiation in other organisms, especially in 
yeast where evidence suggests that translation is inhibited 
during NMD (Muhlrad and Parker, 1999). A better understand-
ing of the signal(s) inducing productive Upf1 recruitment will 
be essential to decipher its downstream mode of action in 
mRNA decay and/or translation.
Perspectives
The compartmentalization of mRNA production and protein 
translation in eukaryotes most likely increases the efficiency of 
these processes, although it makes gene expression slower in 
eukaryotes when compared to prokaryotic cells. The physical 
decoupling of mRNA production from translation might also 
make it difficult to distinguish newly made mRNAs from older 
ones. Yet, this is not the case, at least not in mammalian cells 
where the EJC provides a molecular stamp with which cells are 
able differentiate newly made mRNAs from older transcripts. 
The platform established by the core of the EJC functions in 
several posttranscriptional regulatory steps including mRNA 
decay, localization, and translation through interaction with 
specific factors. It is likely that additional new functions of the 
EJC will be discovered. Interestingly, most functions of the 
EJC appear to be directly or indirectly connected to transla-
tional activation or repression. For example, mRNA localiza-
tion needs to be tightly coordinated with translational control 
to prevent the production of proteins at unwanted places in 
the cell. Future studies will undoubtedly reveal how enhance-
ment or repression of translation involving the EJC may tar-
get different mRNAs in the same cell. Interestingly, the core 
EJC protein eIF4AIII is highly similar to the translation initiation 
factor eIF4A and may be an evolutionary relic indicative of the 
tight functional relationship between the EJC and translation. 
Surprisingly, despite the clear advantages provided by EJCs in 216 Cell 133, April 18, 2008 ©2008 Elsevier Inc.the control of gene expression, conservation of the subunits of 
this complex appears to be limited to metazoans. Neverthe-
less, processes such as NMD, mRNA localization, and transla-
tional enhancement of spliced mRNAs also occur in organisms 
in which EJCs are not supposed to be present, as has been 
reported for the yeast Saccharomyces cerevisiae (Juneau et 
al., 2006). It will be of interest to identify other features of newly 
made mRNAs that promote their recognition by key cellular 
machineries.
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